Mirna Therapeutics Investors

24 investors on Angel Roster list Mirna Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Mirna Therapeutics can appear together.

Investors listed
24
With verified email
58%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Mirna Therapeutics investors

The most complete profiles first. Showing 24 of 24.

  • Dennis McWilliamsVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 32 more

    Verified email available

  • Derek DedekerVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Douglas FrenchVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Ed MathersVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BHealth CareE-commerceWomen FoundedEnterprise Software

    Portfolio: Rhythm Pharmaceuticals, Motus Therapeutics, Sentry, ObsEva and 15 more

    Verified email available

  • Joe CunninghamVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Louis BockVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, diaDexus, Healthcare Highways and 33 more

    Contact details available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Casey CunninghamVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • David KaufmanVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Derek MazurVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • James EadieVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Matt CrawfordVerified

    Venture Capital, Private Equity Firm · United States

    Health CareLife ScienceDiabetesManufacturing

    Portfolio: Tryton Medical, GlycoMimetics, Ortho Kinematics, Intersect ENT and 13 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Eric Epstein

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • Kevin Lalande

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Jason Brandt , CPA

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Mirna Therapeutics investors are on Angel Roster?

Angel Roster lists 24 Mirna Therapeutics investors. 14 of them (58%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (24), Private Equity Firms (3) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Mirna Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (11), Series B (2) and Series A (1).

Where are Mirna Therapeutics investors based?

Most are based in the United States (23) and Canada (1).

Which companies have Mirna Therapeutics investors backed?

The most-backed portfolio companies among them are Lumos Pharma (13), Spinal Restoration (12), LumaTherm (12), Molecular Templates (12) and Laguna Pharmaceuticals (12).

How do I contact Mirna Therapeutics investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.